Reply to: 'IMPRES does not reproducibly predict response to immune checkpoint blockade therapy in metastatic melanoma'

Noam Auslander¹, Joo Sang Lee^{2

3}, Eytan Ruppin⁴

Affiliations

¹ National Center for Biotechnology Information, National Library of Medicine, US National Institutes of Health, Bethesda, MD, USA.
² Cancer Data Science Lab (CDSL), National Cancer Institute, US National Institutes of Health, Bethesda, MD, USA.
³ Samsung Medical Center, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
⁴ Cancer Data Science Lab (CDSL), National Cancer Institute, US National Institutes of Health, Bethesda, MD, USA. eyruppin@gmail.com.

Comment

Noam Auslander et al. Nat Med. 2019 Dec.

. 2019 Dec;25(12):1836-1838.

doi: 10.1038/s41591-019-0646-5. Epub 2019 Dec 5.

Noam Auslander¹, Joo Sang Lee^{2

3}, Eytan Ruppin⁴

¹ National Center for Biotechnology Information, National Library of Medicine, US National Institutes of Health, Bethesda, MD, USA.
² Cancer Data Science Lab (CDSL), National Cancer Institute, US National Institutes of Health, Bethesda, MD, USA.
³ Samsung Medical Center, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
⁴ Cancer Data Science Lab (CDSL), National Cancer Institute, US National Institutes of Health, Bethesda, MD, USA. eyruppin@gmail.com.

No abstract available

Comment on

Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma.
Auslander N, Zhang G, Lee JS, Frederick DT, Miao B, Moll T, Tian T, Wei Z, Madan S, Sullivan RJ, Boland G, Flaherty K, Herlyn M, Ruppin E. Auslander N, et al. Nat Med. 2018 Oct;24(10):1545-1549. doi: 10.1038/s41591-018-0157-9. Epub 2018 Aug 20. Nat Med. 2018. PMID: 30127394 Free PMC article.
IMPRES does not reproducibly predict response to immune checkpoint blockade therapy in metastatic melanoma.
Carter JA, Gilbo P, Atwal GS. Carter JA, et al. Nat Med. 2019 Dec;25(12):1833-1835. doi: 10.1038/s41591-019-0671-4. Epub 2019 Dec 5. Nat Med. 2019. PMID: 31806907 No abstract available.

1. Carter, J. A. et al. IMPRES does not reproducibly predict response to immune checkpoint blockade therapy in metastatic melanoma. Nat. Med. https://doi.org/10.1038/s41591-019-0671-4 (2019).
1. Auslander, N. et al. Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma.Nat. Med. 24, 1545–1549 (2018). - DOI
1. Rudlof, S. & Köppen, M. Stochastic hill climbing with learning by vectors of normal distributions. in Proceedings of the First Online Workshop on Soft Computing (WSC1) 60–70 (1996).
1. Patrick, K. Comparison of simulated annealing and hill climbing in the course timetabling problem. Afr. J. Math. Comput. Sci. Res. 5, 176–178 (2012). - DOI
1. Jacobson, S. H. & Yücesan, E. Analyzing the performance of generalized hill climbing algorithms. J. Heuristics 10, 387–405 (2004). - DOI